Cargando…
Rising CNS Polypharmacy Among Older Adults in the United States
CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743137/ http://dx.doi.org/10.1093/geroni/igaa057.2689 |
_version_ | 1783624146370953216 |
---|---|
author | Maust, Donovan |
author_facet | Maust, Donovan |
author_sort | Maust, Donovan |
collection | PubMed |
description | CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased among older adults, along with the data suggesting there are associated harms. In addition, he will review recent evidence from the Department of Veterans Affairs, which suggests that older Veterans who use both Medicare and the VA system for medical care are at higher risk of potentially inappropriate CNS-active prescribing. Part of a symposium sponsored by the Aging, Alcohol and Addictions Interest Group. |
format | Online Article Text |
id | pubmed-7743137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77431372020-12-21 Rising CNS Polypharmacy Among Older Adults in the United States Maust, Donovan Innov Aging Abstracts CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased among older adults, along with the data suggesting there are associated harms. In addition, he will review recent evidence from the Department of Veterans Affairs, which suggests that older Veterans who use both Medicare and the VA system for medical care are at higher risk of potentially inappropriate CNS-active prescribing. Part of a symposium sponsored by the Aging, Alcohol and Addictions Interest Group. Oxford University Press 2020-12-16 /pmc/articles/PMC7743137/ http://dx.doi.org/10.1093/geroni/igaa057.2689 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstracts Maust, Donovan Rising CNS Polypharmacy Among Older Adults in the United States |
title | Rising CNS Polypharmacy Among Older Adults in the United States |
title_full | Rising CNS Polypharmacy Among Older Adults in the United States |
title_fullStr | Rising CNS Polypharmacy Among Older Adults in the United States |
title_full_unstemmed | Rising CNS Polypharmacy Among Older Adults in the United States |
title_short | Rising CNS Polypharmacy Among Older Adults in the United States |
title_sort | rising cns polypharmacy among older adults in the united states |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743137/ http://dx.doi.org/10.1093/geroni/igaa057.2689 |
work_keys_str_mv | AT maustdonovan risingcnspolypharmacyamongolderadultsintheunitedstates |